Authors:
BUNCH C
MOTOKUBOTA T
ERAN H
HELDEBRANT C
BHATTACHARYA P
Citation: C. Bunch et al., THE INACTIVATION OF HEPATITIS-A VIRUS DURING THE DRY HEAT STEP IN A HIGH-PURITY FACTOR-VIII PRODUCT ALPHANATC(R), Blood, 90(10), 1997, pp. 686-686
Authors:
GALE RE
BUNCH C
MOIR DJ
PATTERSON KG
GOLDSTONE AH
LINCH DC
Citation: Re. Gale et al., DEMONSTRATION OF DEVELOPING MYELODYSPLASIA ACUTE MYELOID-LEUKEMIA IN HEMATOLOGICALLY NORMAL-PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION USING X-CHROMOSOME INACTIVATION PATTERNS, British Journal of Haematology, 93(1), 1996, pp. 53-58
Citation: P. Bhattacharya et al., CHARACTERISTICS AND VIRAL SAFETY OF ALPHANATE AND ITS HEAT-TREATED VERSION, Thrombosis and haemostasis, 73(6), 1995, pp. 1013-1013
Citation: Sw. Herring et al., CHARACTERISTICS AND SAFETY OF A DOUBLE VIRALLY INACTIVATED COAGULATION FACTOR-IX PRODUCT, Thrombosis and haemostasis, 73(6), 1995, pp. 1021-1021
Authors:
HARGREAVES RM
LEA JR
GRIFFITHS H
FAUX JA
HOLT JM
REID C
BUNCH C
LEE M
CHAPEL HM
Citation: Rm. Hargreaves et al., IMMUNOLOGICAL FACTORS AND RISK OF INFECTION IN PLATEAU-PHASE MYELOMA, Journal of Clinical Pathology, 48(3), 1995, pp. 260-266
Authors:
ZHANG C
LAMBERT MP
BUNCH C
BARBER K
WADE WS
KRAFFT GA
KLEIN WL
Citation: C. Zhang et al., FOCAL ADHESION KINASE EXPRESSED BY NERVE-CELL LINES SHOWS INCREASED TYROSINE PHOSPHORYLATION IN RESPONSE TO ALZHEIMERS ALPHA-BETA PEPTIDE, The Journal of biological chemistry, 269(41), 1994, pp. 25247-25250
Authors:
CHAPEL H
DICATO M
GAMM H
BRENNAN V
RIES F
BUNCH C
LEE M
Citation: H. Chapel et al., IMMUNOGLOBULIN REPLACEMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - A COMPARISON OF 2 DOSE REGIMES, British Journal of Haematology, 88(1), 1994, pp. 209-212
Authors:
MOSS PAH
GILLESPIE G
REYBURN H
BUNCH C
BELL JI
Citation: Pah. Moss et al., DEVELOPMENT OF A LARGE GRANULAR LYMPHOCYTE EXPANSION AND COINCIDENT NEUTROPENIA FOLLOWING SUCCESSFUL TREATMENT OF LYMPHOBLASTIC LYMPHOMA, Blood, 84(10), 1994, pp. 10000645-10000645
Authors:
ROLF J
TANIGUCHI T
RANEY J
SILVA R
BUNCH C
BHATTACHARYA P
UEMURA Y
Citation: J. Rolf et al., PURIFICATION, BIOCHEMICAL-CHARACTERIZATION, VIRUS REMOVAL STUDIES, AND PRECLINICAL SAFETY EVALUATION OF A HUMAN ALPHA-1 PROTEINASE-INHIBITOR (A1PI) PREPARATION FOR REPLACEMENT THERAPY OF HEREDITARY A1PI DEFICIENCY, Blood, 84(10), 1994, pp. 10000671-10000671